Tailoring the targeted treatment of chronic lymphocytic leukemia
The scope of the CLL-CLUE project is to implement artificial intelligence-based clinical decision support systems to guide treatment decisions for patients with CLL. It is expected that this will lead to significantly increased treatment efficacy, individualization of therapy and reduced drug use and side effects. In addition, reduced consumption of drugs and cost-effective outcomes will lower financial stress that the health care providers and patients experience.
 | Please follow us on @CLL_CLUE! |
This work is supported by a grant of:
| The Research Council of Norway (RCN) | Academy of Finland, (AKA) | German Federal Ministry of Education and Research (BMBF) | Innovation Fond Denmark, IFD | Romanian National Authority for Scientific Research and Innovation, CCDI – UEFISCDI, project number ERANET-PERMED-CLL-CLUE 196, within PNCDI III |
 |  |  |  |  |